Trump is changing Medicare, mostly focusing on providers. But the biggest impact may come from tariffs and deporting ...

Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural ...

Days after he sent letters instructing top pharmaceutical manufacturers to use a “most favored nation” pricing model for ...

Dr. Mehmet Oz, the Administrator of the Centers for Medicare and Medicaid Services, discussed the impending changes to the ...

The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...

Proposed experiment would allow states and Medicare drug plans to cover GLP-1 drugs like Ozempic and Wegovy for obesity, The ...

People who get subsidized coverage through what’s known as Medicare Savings Programs get to keep hundreds of dollars per ...

The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the ...

The recent tax measures introduced by President Donald Trump have sparked debate over their impact on American finances, particularly for seniors, and the sustainability of vital federal programs like ...

As Medicare and Medicaid turn 60, new Trump-era policies like the 'One Big Beautiful Bill Act' reshape U.S. healthcare, with ...

The drugs reportedly under consideration for coverage include Novo Nordisk's Wegovy and Ozempic, and Eli Lilly's Zepbound and ...

Republicans lambasted Democrats last year for subsidizing monthly payments that seniors pay for prescription drug insurance, ...